Clinical Trials: Find a Clinical Trial

At any time Memorial Sloan Kettering Cancer Center is conducting hundreds of clinical trials to improve care for many types of cancer. Use the tool below to browse our clinical trials that are currently enrolling new patients. Each listing explains the purpose of the trial, the trial’s eligibility criteria, and how to get more information.

The list below includes clinical trials for adult cancers. Please visit our pediatric cancer care section to find a pediatric clinical trial.

Showing 16 trials
Title Investigatorsort icon Disease(s)
A Phase I Study of AM0010 in Patients with Advanced Solid Tumors
[Protocol 13-224]
Autio, Karen
  • Colorectal Cancer
  • Kidney Cancer
  • Lung Cancer
  • Melanoma
  • Ovarian Cancer
  • Prostate Cancer
    • Metastatic Disease after Hormone-Reducing Therapy
  • Upper Gastrointestinal
    • Pancreatic Cancer
A Phase I Study of MEDI4736 in Patients with Advanced Solid Tumors
[Protocol 13-198]
Callahan, Margaret
  • Cervical Cancer
  • Colorectal Cancer
  • Head & Neck Cancer
  • Kidney Cancer
  • Lung Cancer, Non-Small Cell
  • Ovarian Cancer
  • Solid Tumors
A Phase II Study of Gemcitabine and Cisplatin before Surgery in Patients with High-Grade Upper Tract Urothelial Carcinoma
[Protocol 10-208]
Coleman, Jonathan
  • Kidney Cancer
Cabozantinib versus Sunitinib for Treating Previously Untreated Locally Advanced or Metastatic Renal Cell Cancer
[Protocol 14-072]
Feldman, Darren
  • Kidney Cancer
Renal Tumor Classification, Biology, and Banking Study
[Protocol 12-014]
Kobos, Rachel
  • Kidney Cancer
A Phase II Trial of Everolimus and Bevacizumab in Advanced Non-Clear Cell Renal Cell Cancer
[Protocol 10-226]
Molina, Ana Maria
  • Kidney Cancer
A Phase III Study of Cabozantinib versus Everolimus in Patients with Progressive Kidney Cancer
[Protocol 13-124]
Motzer, Robert
  • Kidney Cancer
A Phase II Study of MPDL3280A Alone or with Bevacizumab versus Sunitinib Alone in Patients with Previously Untreated Advanced Renal Cell Cancer
[Protocol 13-212]
Motzer, Robert
  • Kidney Cancer
A Phase III Study of Gemcitabine and Cisplatin with and without Bevacizumab in Patients with Advanced Transitional Cell Carcinoma
[Protocol 12-119]
Rosenberg, Jonathan
  • Bladder Cancer
  • Kidney Cancer
A Phase II Study of Docetaxel Alone or with OGX-427 in Patients with Recurrent or Refractory Urothelial Cancers
Relapsed/Refractory
[Protocol 13-127]
Rosenberg, Jonathan
  • Bladder Cancer
  • Kidney Cancer
A Phase I Study of MEDI4736 in Patients with Advanced Solid Tumors
[Protocol 12-179]
Segal, Neil
  • Colorectal Cancer
  • Kidney Cancer
  • Lung Cancer, Non-Small Cell
  • Melanoma
A Phase I Study of Lirilumab plus Nivolumab in Patients with Advanced Solid Tumors
[Protocol 12-224]
Segal, Neil
  • Colorectal Cancer
  • Kidney Cancer
  • Lung Cancer, Non-Small Cell
  • Melanoma
  • Ovarian Cancer
A Phase I Study of Nivolumab in Combination with Sunitinib, Pazopanib, or Ipilimumab in Patients with Metastatic Renal Cell Carcinoma
[Protocol 12-147]
Voss, Martin
  • Kidney Cancer
A Phase II Study of Axitinib plus Dalantercept or Placebo for Patients with Metastatic Kidney Cancer
[Protocol 12-255]
Voss, Martin
  • Kidney Cancer
A Phase II Study of SNX-5422 in Patients with Select Advanced HER2 Cancers
[Protocol 13-112]
Voss, Martin
  • Bladder Cancer
  • Breast Cancer
  • Kidney Cancer
  • Lung Cancer, Non-Small Cell
  • Upper Gastrointestinal
    • Esophageal Cancer
    • Gastric Cancer
A Phase I Study of INK128 (MLN0128) in Patients with Advanced Kidney, Bladder, or Endometrial Cancer
[Protocol 13-118]
Voss, Martin
  • Bladder Cancer
  • Kidney Cancer